Expression of β-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 1, 2005, Pages 83-87

  Daa, T ^a   Kaku, N ^a   Kashima, K ^a   Nakayama, I ^a   Yokoyama, S ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

catenin; Adenoyd cistic carcinoma; Cyclin D1; E cadherin; Salivary gland

Indexed keywords

BETA CATENIN; CYCLIN D1; UVOMORULIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER CELL; CELL MEMBRANE; CELL NUCLEUS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALIVARY GLAND CARCINOMA;

BASE SEQUENCE; BETA CATENIN; CADHERINS; CARCINOMA, ADENOID CYSTIC; CELL NUCLEUS; CYCLIN D1; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; SALIVARY GLAND NEOPLASMS; TRANS-ACTIVATORS;

EID: 18544384813     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Novak A., Dedhar S.: Signaling through β-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56:523-537, 1999.
2. Ben-Ze'ev A., Shtutman M., Zhurinsky J.: The integration of cell adhesion with gene expression: the role of β-catenin. Exp. Cell Res. 261:75-82, 2000.
3. Boxer L.M., Dang C.V.: Translocations involving c-myc and c-myc function. Oncogene 20:5595-5610, 2001.
4. Amati B., Frank S.R., Donjerkovic D., Taubert S.: Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta. 21:M135-145, 2001.
5. Wu R., Zhai Y., Fearon E.R., Cho K.R.: Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 61:8247-8255, 2001.
6. Grabsch H., Takeno S., Noguchi T., Hommel G., Gabbert H.E., Mueller W.: Different patterns of β-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 39:141-149, 2001.
7. Shigemitsu K., Sekido Y., Usami N., et al.: Genetic alteration of the β-catenin gene (CTNNBl) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene 20:4249-4257, 2001.
8. Chan E.F., Gat U., McNiff J.M., Fuchs E.: A common human skin tumour is caused by activating mutations in β-catenin. Nature Genet. 21:410-413, 1999.
9. Mirabelli-Primdahl L., Gryfe R., Kim H., et al.: β-Catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 59:3346-3351, 1999.
10. Sagae S., Kobayashi K., Nishioka Y., et al: Mutational analysis of β-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas. Jpn. J. Cancer Res. 90:510-515, 1999.
11. Gamallo C., Palacios J., Moreno G., Calvo de Mora J., Suarez A., Armas A.: β-catenin expression pattern in stage I and II ovarian carcinomas: relationship with β-catenin gene mutations, clinicopathological features and clinical outcome. Am. J. Pathol. 155:527-536, 1999.
12. Zhang Z.Y., Wu Y.Q., Zhang W.G., Tian Z., Cao J.: The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands. Chin. J. Dent. Res. 3:36-39, 2000.
13. Morin PJ.: β-Catenin signaling and cancer. Bioessays 21:1021-1030, 1999.
14. Shtutman M., Zhurinsky J., Simcha I., et al.: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. 96:5522-5527, 1999.
15. Palacios J., Gamallo C.: Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58:1344-1347, 1998.
16. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W.: Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58:1130-1134, 1998